← FDA Drug Approvals (Drugs@FDA)

NAMENDA

NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2005-04-18

Drug application

FDA Application #

NDA021627

Application type

New Drug Application

Brand name

NAMENDA

Generic name

Memantine Hydrochloride

Active ingredients

MEMANTINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

ALLERGAN

First approval

2005-04-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown